Improving the way we assign prostate cancer treatment

A Norwegian research group has just received EUR 1.5 million from the EU's Horizon 2020 programme to support their work, which in part looks for clinical diagnostic markers that can help prevent overtreatment of prostate cancer.

Improving the way we assign prostate cancer treatment

Prostate cancer is the most common cancer among men in Europe. Every year around 5000 men in Norway are diagnosed with the disease.

Thu 14 Sep 17 from Medical Xpress

Improving the way we assign prostate cancer treatment, Thu 14 Sep 17 from AlphaGalileo

  • Pages: 1

Bookmark

Bookmark and Share